Couser WG. The pathogenesis of human membranous nephropathy: we are (almost) there. Kidney Int. 2020;97(5):849–52.
Article
CAS
Google Scholar
Beck L, Bonegio R, Lambeau G, Beck D, Powell D, Cummins T, Klein J, Salant D. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21.
Article
CAS
Google Scholar
Vriese AD, Glassock RJ, Nath KA, Sethi S, Fervenza FC. A proposal for a serology-based approach to membranous nephropathy. J Am Soc Nephrol. 2017;28(2):421–30.
Ronco P, Debiec H. Pathophysiological advances in membranous nephropathy: time for a shift in patient’s care. Lancet. 2015;385(9981):1983–92.
Article
Google Scholar
Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X. Long-term exposure to air pollution and increased risk of membranous nephropathy in China. J Am Soc Nephrol. 2016;27:3739–46.
Article
CAS
Google Scholar
Meijers B, Evenepoel P, Anders HJ. Intestinal microbiome and fitness in kidney disease. Nat Rev Nephrol. 2019;15(9):531–45.
Article
Google Scholar
Frank DN, St. Amand AL, Feldman RA. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci. 2007;104(34):13780–5.
Article
CAS
Google Scholar
Ott S, Musfeldt M, Wenderoth D, Hampe J, Brant O, Fölsch U, Timmis K, Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53(5):685–93.
Article
CAS
Google Scholar
Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480.
Article
CAS
Google Scholar
Karlsson FH, Tremaroli V, Nookaew I, Bergstroem G, Behre CJ, Fagerberg B, Nielsen J, Baeckhed F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103.
Article
CAS
Google Scholar
Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, Casella G, Drew JC, Ilonen J, Knip M. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One. 2011;6(10):e25792.
Article
CAS
Google Scholar
Vaahtovuo J, Munukka E, Korkeamaki M, Luukkainen R, Toivanen P, KorkeamäKi M, Luukkainen R, Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol. 2008;35(8):1500–5.
CAS
PubMed
Google Scholar
Penders J, Thijs C, Van D, Kummeling I, Snijders B, Stelma F, Adams H, Ree RV, Stobberingh EE. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut. 2007;56(5):661–7.
Article
CAS
Google Scholar
Chen Y, Yang F, Lu H, Wang B, Li L. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 2011;54(2):562–72.
Article
Google Scholar
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63.
Article
CAS
Google Scholar
Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol. 2004;70(11):6459–65.
Article
CAS
Google Scholar
Parracho HM. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol. 2005;54(10):987–91.
Article
Google Scholar
Scanlan P, Shanahan F, Clune Y, Collins J, O’Sullivan G, O’Riordan M, Holmes E, Wang Y, Marchesi J. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol. 2008;10(3):789–98.
Article
CAS
Google Scholar
Sobhani I, Tap J, Roudot-Thoraval F, Roperch J, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet J. Microbial dysbiosis in colorectal cancer (CRC) patients. PloS One. 2011;6(1):e16393.
Article
CAS
Google Scholar
Debiec H, Lefeu F, Kemper M, Niaudet P, Deschênes G, Remuzzi G, Ulinski T, Ronco P. Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med. 2011;364(22):2101–10.
Article
CAS
Google Scholar
Zhang J, Luo D, Lin Z, Zhou W, Rao J, Li Y, Wu J, Peng H, Lou T. Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome. Microb Pathog. 2020;147:104359.
Article
CAS
Google Scholar
Lang R, Wang X, Li A, Liang Y, Zhu B, Shi B, Zheng Y, Yu R. Effects of Jian Pi Qu Shi Formula on intestinal bacterial flora in patients with idiopathic membranous nephropathy: a prospective randomized controlled trial. Chronic Dis Transl Med. 2020;6(2):124–33.
PubMed
PubMed Central
Google Scholar
Dong R, Bai M, Zhao J, Wang D, Ning X, Sun S. A comparative study of the gut microbiota associated with immunoglobulin a nephropathy and membranous nephropathy. Front Cell Infect Microbiol. 2020;10:557368.
Article
CAS
Google Scholar
He H, Lin M, You L, Chen T, Liang Z, Li D, Xie C, Xiao G, Ye P, Kong Y, et al. Gut microbiota profile in adult patients with idiopathic nephrotic syndrome. Biomed Res Int. 2021;2021:8854969.
PubMed
PubMed Central
Google Scholar
Huang X, Fan X, Ying J, Chen S. Emerging trends and research foci in gastrointestinal microbiome. J Transl Med. 2019;17(1):67.
Article
Google Scholar
Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007;449(7164):811–8.
Article
CAS
Google Scholar
Yatsunenko T, Rey F, Manary M, Trehan I, Dominguez-Bello M, Contreras M, Magris M, Hidalgo G, Baldassano R, Anokhin A, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–7.
Article
CAS
Google Scholar
Macfarlane S, Macfarlane G. Regulation of short-chain fatty acid production. Proc Nutr Soc. 2003;62(1):67–72.
Article
CAS
Google Scholar
Wong J, Piceno Y, DeSantis T, Pahl M, Andersen G, Vaziri N. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol. 2014;39(3):230–7.
Article
CAS
Google Scholar
Onal E, Afsar B, Covic A, Vaziri N, Kanbay M. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease. Hypertens Res. 2019;42(2):123–40.
Article
Google Scholar
Mirpuri J, Raetz M, Sturge C, Wilhelm C, Benson A, Savani R, Hooper L, Yarovinsky F. Proteobacteria-specific IgA regulates maturation of the intestinal microbiota. Gut Microbes. 2014;5(1):28–39.
Article
Google Scholar
Salguero M, Al-Obaide M, Singh R, Siepmann T, Vasylyeva T. Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease. Exp Ther Med. 2019;18(5):3461–9.
CAS
PubMed
PubMed Central
Google Scholar
de Paiva C, Jones D, Stern M, Bian F, Moore Q, Corbiere S, Streckfus C, Hutchinson D, Ajami N, Petrosino J, et al. Altered mucosal microbiome diversity and disease severity in Sjögren syndrome. Sci Rep. 2016;6:23561.
Article
Google Scholar
Companys J, Gosalbes M, Pla-Pagà L, Calderón-Pérez L, Llauradó E, Pedret A, Valls R, Jiménez-Hernández N, Sandoval-Ramirez B, Del Bas J, et al. Gut microbiota profile and its association with clinical variables and dietary intake in overweight/obese and lean subjects: a cross-sectional study. Nutrients. 2021;13(6):2032.
Article
CAS
Google Scholar
Moayyeri A, Hammond C, Valdes A, Spector T. Cohort Profile: TwinsUK and healthy ageing twin study. Int J Epidemiol. 2013;42(1):76–85.
Article
Google Scholar
Moorhead J, Wheeler D, Varghese Z. Glomerular structures and lipids in progressive renal disease. Am J Med. 1989;87:12N-20N.
CAS
PubMed
Google Scholar
Ma H, Sandor D, Beck L. The role of complement in membranous nephropathy. Semin Nephrol. 2013;33(6):531–42.
Article
CAS
Google Scholar
Zhou G, Zeng J, Peng L, Wang L, Zheng W, Wu Di, Yang Y. Fecal microbiota transplantation for membranous nephropathy. CEN Case Rep. 2021;10(2):261–4.
Article
Google Scholar